Higher Risk of Blood Clots From COVID-19 Than Vaccines 19/04/2021 Chandre Prince The risk of developing a rare brain blood clot is eight to ten times higher in people infected with COVID-19 than those who get a vaccine, a new study has found. The study by Oxford University last week reported that the risk of the rare blood clotting known as cerebral venous thrombosis (CVT) following COVID-19 […] Continue reading -> People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Cities Credit Communication, Trust-building and Data for COVID-19 Successes 16/04/2021 Chandre Prince A real-time COVID-19 data dashboard, celebrities and athletes sharing information about COVID-19 and vaccine hesitancy, rapid response task teams and public communications campaigns have formed part of response strategies to help two major cities fight the pandemic. The Partnership for Healthy Cities – supported by Bloomberg Philanthropies, the World Health Organization and Vital Strategies— on […] Continue reading -> Papua New Guinea’s COVID-19 Surge Coincides With ‘Worrying’ Global Increases, Say WHO Officials 16/04/2021 Madeleine Hoecklin As the world quickly approaches the highest weekly rate of infection recorded since the start of the pandemic over a year ago, several countries that have largely held COVID-19 at bay so far are seeing surges in infections. Papua New Guinea (PNG), a small Pacific island state that successfully shielded itself from the SARS-CoV2 virus […] Continue reading -> Kenya’s COVID-19 Vaccine Rollout: All Ready to Go, But No Doses Available 16/04/2021 Geoffrey Kamadi NAIROBI – Kenya has developed an ambitious COVID-19 vaccination rollout plan – but it has only received enough doses for a million of its 50 million citizens, and dispensed slightly more than half of these – 565,000 – to health workers. Kenya is currently in the third wave of the pandemic and estimates that 4 […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> Many Africans May Not Receive Their Second COVID-19 Vaccine Doses Anytime Soon, Africa CDC Warns 15/04/2021 Paul Adepoju IBADAN – The Africa CDC has expressed concerns over the disruption of the COVID-19 vaccination drive in Africa saying it was preventing many Africans who have received the first dose of the Oxford/AstraZeneca vaccine may not be able to receive the second dose 12 weeks after the first dose as recommended in the vaccination guideline. […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> UK COVID-19 Variant Not Linked to Severe Disease or Reinfection – New Lancet Study 14/04/2021 Editorial team Two studies published by The Lancet Infectious Disease and The Lancet Public Health report that the United Kingdom’s dominant strain of the virus is not linked to more severe disease or death, and that there was no apparent increase in reinfection rate from the variant. The variant of SARS-CoV-2 2, B.1.1.7, emerged as the dominant […] Continue reading -> India Set To Become Major Manufacturing Hub Of Sputnik V COVID Vaccine – Regulatory Approval Comes As COVID Cases Spike 14/04/2021 Menaka Rao India has greenlighted Russia’s Sputnik V vaccine for emergency use following a severe shortage of vaccines against the coronavirus and a massive spike in cases, and is now poised to become one of the world’s largest manufacturing hubs for the vaccine with 50 million doses produced by July. India’s aproval of a third COVID vaccine […] Continue reading -> Posts navigation Older postsNewer posts
People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Cities Credit Communication, Trust-building and Data for COVID-19 Successes 16/04/2021 Chandre Prince A real-time COVID-19 data dashboard, celebrities and athletes sharing information about COVID-19 and vaccine hesitancy, rapid response task teams and public communications campaigns have formed part of response strategies to help two major cities fight the pandemic. The Partnership for Healthy Cities – supported by Bloomberg Philanthropies, the World Health Organization and Vital Strategies— on […] Continue reading -> Papua New Guinea’s COVID-19 Surge Coincides With ‘Worrying’ Global Increases, Say WHO Officials 16/04/2021 Madeleine Hoecklin As the world quickly approaches the highest weekly rate of infection recorded since the start of the pandemic over a year ago, several countries that have largely held COVID-19 at bay so far are seeing surges in infections. Papua New Guinea (PNG), a small Pacific island state that successfully shielded itself from the SARS-CoV2 virus […] Continue reading -> Kenya’s COVID-19 Vaccine Rollout: All Ready to Go, But No Doses Available 16/04/2021 Geoffrey Kamadi NAIROBI – Kenya has developed an ambitious COVID-19 vaccination rollout plan – but it has only received enough doses for a million of its 50 million citizens, and dispensed slightly more than half of these – 565,000 – to health workers. Kenya is currently in the third wave of the pandemic and estimates that 4 […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> Many Africans May Not Receive Their Second COVID-19 Vaccine Doses Anytime Soon, Africa CDC Warns 15/04/2021 Paul Adepoju IBADAN – The Africa CDC has expressed concerns over the disruption of the COVID-19 vaccination drive in Africa saying it was preventing many Africans who have received the first dose of the Oxford/AstraZeneca vaccine may not be able to receive the second dose 12 weeks after the first dose as recommended in the vaccination guideline. […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> UK COVID-19 Variant Not Linked to Severe Disease or Reinfection – New Lancet Study 14/04/2021 Editorial team Two studies published by The Lancet Infectious Disease and The Lancet Public Health report that the United Kingdom’s dominant strain of the virus is not linked to more severe disease or death, and that there was no apparent increase in reinfection rate from the variant. The variant of SARS-CoV-2 2, B.1.1.7, emerged as the dominant […] Continue reading -> India Set To Become Major Manufacturing Hub Of Sputnik V COVID Vaccine – Regulatory Approval Comes As COVID Cases Spike 14/04/2021 Menaka Rao India has greenlighted Russia’s Sputnik V vaccine for emergency use following a severe shortage of vaccines against the coronavirus and a massive spike in cases, and is now poised to become one of the world’s largest manufacturing hubs for the vaccine with 50 million doses produced by July. India’s aproval of a third COVID vaccine […] Continue reading -> Posts navigation Older postsNewer posts
Cities Credit Communication, Trust-building and Data for COVID-19 Successes 16/04/2021 Chandre Prince A real-time COVID-19 data dashboard, celebrities and athletes sharing information about COVID-19 and vaccine hesitancy, rapid response task teams and public communications campaigns have formed part of response strategies to help two major cities fight the pandemic. The Partnership for Healthy Cities – supported by Bloomberg Philanthropies, the World Health Organization and Vital Strategies— on […] Continue reading -> Papua New Guinea’s COVID-19 Surge Coincides With ‘Worrying’ Global Increases, Say WHO Officials 16/04/2021 Madeleine Hoecklin As the world quickly approaches the highest weekly rate of infection recorded since the start of the pandemic over a year ago, several countries that have largely held COVID-19 at bay so far are seeing surges in infections. Papua New Guinea (PNG), a small Pacific island state that successfully shielded itself from the SARS-CoV2 virus […] Continue reading -> Kenya’s COVID-19 Vaccine Rollout: All Ready to Go, But No Doses Available 16/04/2021 Geoffrey Kamadi NAIROBI – Kenya has developed an ambitious COVID-19 vaccination rollout plan – but it has only received enough doses for a million of its 50 million citizens, and dispensed slightly more than half of these – 565,000 – to health workers. Kenya is currently in the third wave of the pandemic and estimates that 4 […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> Many Africans May Not Receive Their Second COVID-19 Vaccine Doses Anytime Soon, Africa CDC Warns 15/04/2021 Paul Adepoju IBADAN – The Africa CDC has expressed concerns over the disruption of the COVID-19 vaccination drive in Africa saying it was preventing many Africans who have received the first dose of the Oxford/AstraZeneca vaccine may not be able to receive the second dose 12 weeks after the first dose as recommended in the vaccination guideline. […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> UK COVID-19 Variant Not Linked to Severe Disease or Reinfection – New Lancet Study 14/04/2021 Editorial team Two studies published by The Lancet Infectious Disease and The Lancet Public Health report that the United Kingdom’s dominant strain of the virus is not linked to more severe disease or death, and that there was no apparent increase in reinfection rate from the variant. The variant of SARS-CoV-2 2, B.1.1.7, emerged as the dominant […] Continue reading -> India Set To Become Major Manufacturing Hub Of Sputnik V COVID Vaccine – Regulatory Approval Comes As COVID Cases Spike 14/04/2021 Menaka Rao India has greenlighted Russia’s Sputnik V vaccine for emergency use following a severe shortage of vaccines against the coronavirus and a massive spike in cases, and is now poised to become one of the world’s largest manufacturing hubs for the vaccine with 50 million doses produced by July. India’s aproval of a third COVID vaccine […] Continue reading -> Posts navigation Older postsNewer posts
Papua New Guinea’s COVID-19 Surge Coincides With ‘Worrying’ Global Increases, Say WHO Officials 16/04/2021 Madeleine Hoecklin As the world quickly approaches the highest weekly rate of infection recorded since the start of the pandemic over a year ago, several countries that have largely held COVID-19 at bay so far are seeing surges in infections. Papua New Guinea (PNG), a small Pacific island state that successfully shielded itself from the SARS-CoV2 virus […] Continue reading -> Kenya’s COVID-19 Vaccine Rollout: All Ready to Go, But No Doses Available 16/04/2021 Geoffrey Kamadi NAIROBI – Kenya has developed an ambitious COVID-19 vaccination rollout plan – but it has only received enough doses for a million of its 50 million citizens, and dispensed slightly more than half of these – 565,000 – to health workers. Kenya is currently in the third wave of the pandemic and estimates that 4 […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> Many Africans May Not Receive Their Second COVID-19 Vaccine Doses Anytime Soon, Africa CDC Warns 15/04/2021 Paul Adepoju IBADAN – The Africa CDC has expressed concerns over the disruption of the COVID-19 vaccination drive in Africa saying it was preventing many Africans who have received the first dose of the Oxford/AstraZeneca vaccine may not be able to receive the second dose 12 weeks after the first dose as recommended in the vaccination guideline. […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> UK COVID-19 Variant Not Linked to Severe Disease or Reinfection – New Lancet Study 14/04/2021 Editorial team Two studies published by The Lancet Infectious Disease and The Lancet Public Health report that the United Kingdom’s dominant strain of the virus is not linked to more severe disease or death, and that there was no apparent increase in reinfection rate from the variant. The variant of SARS-CoV-2 2, B.1.1.7, emerged as the dominant […] Continue reading -> India Set To Become Major Manufacturing Hub Of Sputnik V COVID Vaccine – Regulatory Approval Comes As COVID Cases Spike 14/04/2021 Menaka Rao India has greenlighted Russia’s Sputnik V vaccine for emergency use following a severe shortage of vaccines against the coronavirus and a massive spike in cases, and is now poised to become one of the world’s largest manufacturing hubs for the vaccine with 50 million doses produced by July. India’s aproval of a third COVID vaccine […] Continue reading -> Posts navigation Older postsNewer posts
Kenya’s COVID-19 Vaccine Rollout: All Ready to Go, But No Doses Available 16/04/2021 Geoffrey Kamadi NAIROBI – Kenya has developed an ambitious COVID-19 vaccination rollout plan – but it has only received enough doses for a million of its 50 million citizens, and dispensed slightly more than half of these – 565,000 – to health workers. Kenya is currently in the third wave of the pandemic and estimates that 4 […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> Many Africans May Not Receive Their Second COVID-19 Vaccine Doses Anytime Soon, Africa CDC Warns 15/04/2021 Paul Adepoju IBADAN – The Africa CDC has expressed concerns over the disruption of the COVID-19 vaccination drive in Africa saying it was preventing many Africans who have received the first dose of the Oxford/AstraZeneca vaccine may not be able to receive the second dose 12 weeks after the first dose as recommended in the vaccination guideline. […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> UK COVID-19 Variant Not Linked to Severe Disease or Reinfection – New Lancet Study 14/04/2021 Editorial team Two studies published by The Lancet Infectious Disease and The Lancet Public Health report that the United Kingdom’s dominant strain of the virus is not linked to more severe disease or death, and that there was no apparent increase in reinfection rate from the variant. The variant of SARS-CoV-2 2, B.1.1.7, emerged as the dominant […] Continue reading -> India Set To Become Major Manufacturing Hub Of Sputnik V COVID Vaccine – Regulatory Approval Comes As COVID Cases Spike 14/04/2021 Menaka Rao India has greenlighted Russia’s Sputnik V vaccine for emergency use following a severe shortage of vaccines against the coronavirus and a massive spike in cases, and is now poised to become one of the world’s largest manufacturing hubs for the vaccine with 50 million doses produced by July. India’s aproval of a third COVID vaccine […] Continue reading -> Posts navigation Older postsNewer posts
Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> Many Africans May Not Receive Their Second COVID-19 Vaccine Doses Anytime Soon, Africa CDC Warns 15/04/2021 Paul Adepoju IBADAN – The Africa CDC has expressed concerns over the disruption of the COVID-19 vaccination drive in Africa saying it was preventing many Africans who have received the first dose of the Oxford/AstraZeneca vaccine may not be able to receive the second dose 12 weeks after the first dose as recommended in the vaccination guideline. […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> UK COVID-19 Variant Not Linked to Severe Disease or Reinfection – New Lancet Study 14/04/2021 Editorial team Two studies published by The Lancet Infectious Disease and The Lancet Public Health report that the United Kingdom’s dominant strain of the virus is not linked to more severe disease or death, and that there was no apparent increase in reinfection rate from the variant. The variant of SARS-CoV-2 2, B.1.1.7, emerged as the dominant […] Continue reading -> India Set To Become Major Manufacturing Hub Of Sputnik V COVID Vaccine – Regulatory Approval Comes As COVID Cases Spike 14/04/2021 Menaka Rao India has greenlighted Russia’s Sputnik V vaccine for emergency use following a severe shortage of vaccines against the coronavirus and a massive spike in cases, and is now poised to become one of the world’s largest manufacturing hubs for the vaccine with 50 million doses produced by July. India’s aproval of a third COVID vaccine […] Continue reading -> Posts navigation Older postsNewer posts
Many Africans May Not Receive Their Second COVID-19 Vaccine Doses Anytime Soon, Africa CDC Warns 15/04/2021 Paul Adepoju IBADAN – The Africa CDC has expressed concerns over the disruption of the COVID-19 vaccination drive in Africa saying it was preventing many Africans who have received the first dose of the Oxford/AstraZeneca vaccine may not be able to receive the second dose 12 weeks after the first dose as recommended in the vaccination guideline. […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> UK COVID-19 Variant Not Linked to Severe Disease or Reinfection – New Lancet Study 14/04/2021 Editorial team Two studies published by The Lancet Infectious Disease and The Lancet Public Health report that the United Kingdom’s dominant strain of the virus is not linked to more severe disease or death, and that there was no apparent increase in reinfection rate from the variant. The variant of SARS-CoV-2 2, B.1.1.7, emerged as the dominant […] Continue reading -> India Set To Become Major Manufacturing Hub Of Sputnik V COVID Vaccine – Regulatory Approval Comes As COVID Cases Spike 14/04/2021 Menaka Rao India has greenlighted Russia’s Sputnik V vaccine for emergency use following a severe shortage of vaccines against the coronavirus and a massive spike in cases, and is now poised to become one of the world’s largest manufacturing hubs for the vaccine with 50 million doses produced by July. India’s aproval of a third COVID vaccine […] Continue reading -> Posts navigation Older postsNewer posts
‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> UK COVID-19 Variant Not Linked to Severe Disease or Reinfection – New Lancet Study 14/04/2021 Editorial team Two studies published by The Lancet Infectious Disease and The Lancet Public Health report that the United Kingdom’s dominant strain of the virus is not linked to more severe disease or death, and that there was no apparent increase in reinfection rate from the variant. The variant of SARS-CoV-2 2, B.1.1.7, emerged as the dominant […] Continue reading -> India Set To Become Major Manufacturing Hub Of Sputnik V COVID Vaccine – Regulatory Approval Comes As COVID Cases Spike 14/04/2021 Menaka Rao India has greenlighted Russia’s Sputnik V vaccine for emergency use following a severe shortage of vaccines against the coronavirus and a massive spike in cases, and is now poised to become one of the world’s largest manufacturing hubs for the vaccine with 50 million doses produced by July. India’s aproval of a third COVID vaccine […] Continue reading -> Posts navigation Older postsNewer posts
UK COVID-19 Variant Not Linked to Severe Disease or Reinfection – New Lancet Study 14/04/2021 Editorial team Two studies published by The Lancet Infectious Disease and The Lancet Public Health report that the United Kingdom’s dominant strain of the virus is not linked to more severe disease or death, and that there was no apparent increase in reinfection rate from the variant. The variant of SARS-CoV-2 2, B.1.1.7, emerged as the dominant […] Continue reading -> India Set To Become Major Manufacturing Hub Of Sputnik V COVID Vaccine – Regulatory Approval Comes As COVID Cases Spike 14/04/2021 Menaka Rao India has greenlighted Russia’s Sputnik V vaccine for emergency use following a severe shortage of vaccines against the coronavirus and a massive spike in cases, and is now poised to become one of the world’s largest manufacturing hubs for the vaccine with 50 million doses produced by July. India’s aproval of a third COVID vaccine […] Continue reading -> Posts navigation Older postsNewer posts
India Set To Become Major Manufacturing Hub Of Sputnik V COVID Vaccine – Regulatory Approval Comes As COVID Cases Spike 14/04/2021 Menaka Rao India has greenlighted Russia’s Sputnik V vaccine for emergency use following a severe shortage of vaccines against the coronavirus and a massive spike in cases, and is now poised to become one of the world’s largest manufacturing hubs for the vaccine with 50 million doses produced by July. India’s aproval of a third COVID vaccine […] Continue reading -> Posts navigation Older postsNewer posts